SCHEMBL19203577

SCHEMBL19203577

CC(C)C(=O)C(CCCNC(N)=O)NC(=O)CNC(=S)NCCC(C)(C)OCCC(C)(C)C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22767952 1.00 — —
SCHEMBL19171171 0.93 — —
SCHEMBL24722049 0.84 — —
SCHEMBL21322625 0.80 C3AR1 (0.32) —
SCHEMBL21322470 0.75 SIRT5 (0.32) —
SCHEMBL21322629 0.74 C3AR1 (0.34) —
SCHEMBL10076956 0.72 HPGD (0.31) —
SCHEMBL19171189 0.72 — —
SCHEMBL21322486 0.72 — —
SCHEMBL21534501 0.70 SIRT5 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017132173-A1 MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE REGENERON PHARMACEUTICALS, INC. (US) 2017-08-03 — — WO disclosed
Send feedback